Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot

Auris Health is featured in Xconomy for its recent round of fundraising. Auris Health was able to raise an additional $220 million in funding to further bolster its commercialization efforts. Auris received clearance from the FDA to sell the first robotic bronchoscope offered on the Monarch Platform.

Partner Fund Management led this round of funding with new investors that included Wellington Management, D1 Capital Partners and Senator Investment Group and existing investors including Mithril Capital, Lux Capital and Viking Global Investors.

This article further highlighted the robotic technology for endoscopy that uses a flexible scope to access the natural orifices of the body. This cutting-edge technology is designed to enhance the clinicians capabilities when trying to reach and biopsy hard to reach parts of the lung.

The Monarch Platform uses a unique game like controller to navigate the flexible scope deep into the body. This controller combined with robotic technology is designed to enable physicians to steer an endoscope with greater precision.

This recent round of funding is targeted to support the company's fulll commercialization of the Monarch Platform.